Company record
Aurolab Trust
0 FDA warning letters since 2023 and 1 recall in the last 12 months.
Get an email the day FDA posts anything new about Aurolab Trust.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Oct 7 | Class II | Aurolab Trust Drug |
FOCUS PI Hypromellose 0.7% Formula, 0.3 FL O (10 mL) per vial, STERILE, Manufactured for: Covalent Management, Inc., Manassas, VA 20109. NDC: 82724-007-19 Lack of Assurance of Sterility |